PepperLime Health Acquisition Corporation
NASDAQ:PEPL
10.93 (USD) • At close March 21, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
---|---|---|---|---|---|---|---|---|---|
Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Kosten van de omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Brutowinst
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 0.356 | 0.047 | 0.463 | 0.522 | 0.217 | 0.279 | 0.336 | 0.439 | 0.026 |
Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 0.356 | 0.047 | 0.463 | 0.522 | 0.217 | 0.279 | 0.336 | 0.439 | 0.026 |
Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bedrijfskosten
| 0.356 | 0.047 | 0.463 | 0.522 | 0.217 | 0.279 | 0.336 | 0.439 | 0.026 |
Bedrijfsresultaat
| -0.356 | -0.047 | -0.463 | -0.522 | -0.217 | -0.279 | -0.336 | -0.439 | -0.026 |
Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Totaal overige inkomsten en kosten netto
| 0.148 | 0.151 | 0.455 | 1.45 | 0.755 | 0.232 | 0.004 | 0.002 | 0 |
Inkomen voor belasting
| -0.208 | 0.104 | -0.008 | 0.928 | 0.538 | -0.047 | -0.331 | -0.437 | -0.026 |
Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Belastingkosten
| 0 | 0 | -0.455 | -1.008 | -0.648 | -0.232 | -0.004 | -0.002 | 0 |
Nettowinst
| -0.208 | 0.104 | 0.447 | 1.936 | 1.186 | 0.185 | -0.327 | -0.437 | -0.026 |
Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
WPA (Winst Per Aandeel)
| -0.039 | 0.02 | 0.11 | 0.11 | 0.28 | 0.044 | -0.019 | 0 | -0.002 |
Verwaterde WPA
| -0.039 | 0.02 | 0.11 | 0.11 | 0.28 | 0.044 | -0.019 | 0 | -0.002 |
EBITDA
| -0.356 | -0.047 | -0.463 | -0.522 | -0.217 | -0.279 | -0.336 | -0.439 | -0.026 |
EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |